| Literature DB >> 391321 |
K Chakravarty, W Tucker, M Rosen, M D Vickers.
Abstract
In a double-blind study of on-demand intravenous analgesia buprenorphine was found to be about 600 times as potent as pethidine. The incidence of side effects was similar with both drugs. The quality of analgesia, subjectively assessed, was good with both drugs using this method of administration. Provided that its low potential for abuse is substantiated, buprenorphine appears to be a powerful analgesic that may successfully be given intravenously on demand.Entities:
Mesh:
Substances:
Year: 1979 PMID: 391321 PMCID: PMC1596754 DOI: 10.1136/bmj.2.6195.895
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447